These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
979 related items for PubMed ID: 16226889
1. Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: consequences for signaling by VIP and PACAP. Lutz EM, Ronaldson E, Shaw P, Johnson MS, Holland PJ, Mitchell R. Mol Cell Neurosci; 2006 Feb; 31(2):193-209. PubMed ID: 16226889 [Abstract] [Full Text] [Related]
2. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions. Abu-Hamdan MD, Drescher MJ, Ramakrishnan NA, Khan KM, Toma VS, Hatfield JS, Drescher DG. Neuroscience; 2006 Jun 19; 140(1):147-61. PubMed ID: 16626868 [Abstract] [Full Text] [Related]
3. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R. Reproduction; 2007 Aug 19; 134(2):281-92. PubMed ID: 17660238 [Abstract] [Full Text] [Related]
4. Differential intracellular signaling through PAC1 isoforms as a result of alternative splicing in the first extracellular domain and the third intracellular loop. Ushiyama M, Ikeda R, Sugawara H, Yoshida M, Mori K, Kangawa K, Inoue K, Yamada K, Miyata A. Mol Pharmacol; 2007 Jul 19; 72(1):103-11. PubMed ID: 17442841 [Abstract] [Full Text] [Related]
5. Signaling pathways in PACAP regulation of VIP gene expression in human neuroblastoma cells. Falktoft B, Georg B, Fahrenkrug J. Neuropeptides; 2009 Oct 19; 43(5):387-96. PubMed ID: 19712974 [Abstract] [Full Text] [Related]
6. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland. Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG. Int J Mol Med; 2002 Mar 19; 9(3):233-43. PubMed ID: 11836629 [Abstract] [Full Text] [Related]
7. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue. García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC. Gynecol Endocrinol; 2005 Jun 19; 20(6):327-33. PubMed ID: 16019382 [Abstract] [Full Text] [Related]
8. Characterization and expression of different pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide receptors in rat ovarian follicles. Vaccari S, Latini S, Barberi M, Teti A, Stefanini M, Canipari R. J Endocrinol; 2006 Oct 19; 191(1):287-99. PubMed ID: 17065411 [Abstract] [Full Text] [Related]
9. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance. Alexandre D, Vaudry H, Grumolato L, Turquier V, Fournier A, Jégou S, Anouar Y. Endocrinology; 2002 Jul 19; 143(7):2680-92. PubMed ID: 12072402 [Abstract] [Full Text] [Related]
10. PACAP and PAC1 receptor in brain development and behavior. Shen S, Gehlert DR, Collier DA. Neuropeptides; 2013 Dec 19; 47(6):421-30. PubMed ID: 24220567 [Abstract] [Full Text] [Related]
11. Cloning and characterization of a PAC1 receptor hop-1 splice variant in goldfish (Carassius auratus). Kwok YY, Chu JY, Vaudry H, Yon L, Anouar Y, Chow BK. Gen Comp Endocrinol; 2006 Jan 15; 145(2):188-96. PubMed ID: 16225877 [Abstract] [Full Text] [Related]
12. Maxadilan interacts with receptors for pituitary adenylyl cyclase activating peptide in human SH-SY5Y and SK-N-MC neuroblastoma cells. Eggenberger M, Born W, Zimmermann U, Lerner EA, Fischer JA, Muff R. Neuropeptides; 1999 Apr 15; 33(2):107-14. PubMed ID: 10657479 [Abstract] [Full Text] [Related]
13. cAMP activation by PACAP/VIP stimulates IL-6 release and inhibits osteoblastic differentiation through VPAC2 receptor in osteoblastic MC3T3 cells. Nagata A, Tanaka T, Minezawa A, Poyurovsky M, Mayama T, Suzuki S, Hashimoto N, Yoshida T, Suyama K, Miyata A, Hosokawa H, Nakayama T, Tatsuno I. J Cell Physiol; 2009 Oct 15; 221(1):75-83. PubMed ID: 19496170 [Abstract] [Full Text] [Related]
14. Immunocytochemical identification of VPAC1, VPAC2, and PAC1 receptors in normal and neoplastic human tissues with subtype-specific antibodies. Schulz S, Röcken C, Mawrin C, Weise W, Höllt V, Schulz S. Clin Cancer Res; 2004 Dec 15; 10(24):8235-42. PubMed ID: 15623599 [Abstract] [Full Text] [Related]
15. PACAP and VIP prevent apoptosis in schwannoma cells. Castorina A, Tiralongo A, Giunta S, Carnazza ML, Rasi G, D'Agata V. Brain Res; 2008 Nov 19; 1241():29-35. PubMed ID: 18835258 [Abstract] [Full Text] [Related]
16. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI. J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712 [Abstract] [Full Text] [Related]
17. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC. Jamen F, Puech R, Bockaert J, Brabet P, Bertrand G. Endocrinology; 2002 Apr 30; 143(4):1253-9. PubMed ID: 11897681 [Abstract] [Full Text] [Related]
18. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes. Akesson L, Ahrén B, Edgren G, Degerman E. Endocrinology; 2005 Feb 30; 146(2):744-50. PubMed ID: 15514088 [Abstract] [Full Text] [Related]
19. Differential signal transduction by five splice variants of the PACAP receptor. Spengler D, Waeber C, Pantaloni C, Holsboer F, Bockaert J, Seeburg PH, Journot L. Nature; 1993 Sep 09; 365(6442):170-5. PubMed ID: 8396727 [Abstract] [Full Text] [Related]
20. Pituitary adenylyl cyclase-activating polypeptide controls the proliferation of retinal progenitor cells through downregulation of cyclin D1. Njaine B, Martins RA, Santiago MF, Linden R, Silveira MS. Eur J Neurosci; 2010 Aug 09; 32(3):311-21. PubMed ID: 20646049 [Abstract] [Full Text] [Related] Page: [Next] [New Search]